Cargando…

Clinical efficacy of linagliptin combined with irbesartan in patients with diabetic nephropathy

OBJECTIVE: To determine the clinical efficacy of linagliptin combined with irbesartan in patients with diabetic nephropathy (DN). METHODS: Seventy-two patients who were admitted to our department of endocrinology in our hospital during January 2018 and June 2019 were randomly divided into a control...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jie, Zhang, Jing, Hou, Ming-hui, Du, Wei-xuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Professional Medical Publications 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713209/ https://www.ncbi.nlm.nih.gov/pubmed/35035400 http://dx.doi.org/10.12669/pjms.38.1.4417

Ejemplares similares

Irbesartan in experimental diabetic nephropathy
por: Mahajan, Rajiv, et al.
Publicado: (2010)

Biochemical effects of irbesartan in experimental diabetic nephropathy
por: Vaishya, Richa, et al.
Publicado: (2009)

Efficacy of Yishen Huashi Granules Combined with Linagliptin Tablets on Blood Glucose and Renal Function in Patients with Type 2 Diabetic Nephropathy
por: Zhang, Panke, et al.
Publicado: (2022)

The effect of linagliptin on microalbuminuria in patients with diabetic nephropathy: a randomized, double blinded clinical trial
por: Karimifar, Mozhgan, et al.
Publicado: (2023)

Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice
por: Chen, Xiao-Wen, et al.
Publicado: (2016)

Clinical utility and tolerability of linagliptin in diabetic patients
por: Maxwell, Lauralee Gordon, et al.
Publicado: (2013)

Corrigendum to “Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice”
por: Chen, Xiao-Wen, et al.
Publicado: (2016)

Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension
por: Bramlage, Peter
Publicado: (2009)

Combination of Linagliptin and Metformin for the Treatment of Patients with Type 2 Diabetes
por: Haak, Thomas
Publicado: (2015)

Changes of Necroptosis in Irbesartan Medicated Cardioprotection in Diabetic Rats
por: Xu, Qingmei, et al.
Publicado: (2021)

Linagliptin: farmacology, efficacy and safety in type 2 diabetes treatment
por: Guedes, Erika Paniago, et al.
Publicado: (2013)

Comprehensive overview: efficacy, tolerability, and cost-effectiveness of irbesartan
por: Gialama, Fotini, et al.
Publicado: (2013)

Efficacy and Safety of a Fixed Combination of Irbesartan/Hydrochlorothiazide in Chinese Patients with Moderate to Severe Hypertension
por: Huang, Qi-Fang, et al.
Publicado: (2013)

Linagliptin: A thorough Characterization beyond Its Clinical Efficacy
por: Sortino, Maria Angela, et al.
Publicado: (2013)

The clinical application of linagliptin in Asians
por: Cao, Chu-qing, et al.
Publicado: (2015)

Comparison of clinical efficacy of metoprolol combined with irbesartan and hydrochlorothiazide and non-invasive ventilator in the emergency treatment of patients with severe heart failure
por: Zhang, Fangxia, et al.
Publicado: (2018)

Efficacy of Combined Abelmoschus manihot and Irbesartan for Reduction of Albuminuria in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter Randomized Double-Blind Parallel Controlled Clinical Trial
por: Zhao, Jing, et al.
Publicado: (2022)

Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria
por: Persson, Frederik, et al.
Publicado: (2009)

Efficacy of a fixed dose combination of irbesartan and atorvastatin (Rovelito(®)) in Korean adults with hypertension and hypercholesterolemia
por: Ihm, Sang-Hyun, et al.
Publicado: (2019)

Efficacy of Irbesartan on Left Ventricular Mass and Arterial Stiffness in Hypertensive Patients
por: Park, Chang Gyu, et al.
Publicado: (2006)

Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes
por: Nakamura, Makiko, et al.
Publicado: (2014)

Linagliptin improves endothelial function in patients with type 2 diabetes: A randomized study of linagliptin effectiveness on endothelial function
por: Shigiyama, Fumika, et al.
Publicado: (2016)

Effects and Safety of Linagliptin as an Add-on Therapy in Advanced-Stage Diabetic Nephropathy Patients Taking Renin–Angiotensin–Aldosterone System Blockers
por: Ueda, Yuichiro, et al.
Publicado: (2016)

Long-Term Effects of Irbesartan Treatment and Smoking on Nucleic Acid Oxidation in Patients With Type 2 Diabetes and Microalbuminuria: An Irbesartan in Patients With Type 2 Diabetes and Microalbuminuria (IRMA 2) substudy
por: Broedbaek, Kasper, et al.
Publicado: (2011)

Efficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysis
por: Terawaki, Yuichi, et al.
Publicado: (2015)

Oral Formulation Based on Irbesartan Nanocrystals Improve Drug Solubility, Absorbability, and Efficacy
por: Nagai, Noriaki, et al.
Publicado: (2022)

Initial combination therapy for patients with type 2 diabetes mellitus: considerations for metformin plus linagliptin
por: Freeman, Jeffrey S
Publicado: (2013)

Effects of irbesartan on myocardial injury in diabetic rats: The role of NLRP3/ASC/Caspase-1 pathway
por: Rong, Li, et al.
Publicado: (2020)

Linagliptin use in older individuals with type 2 diabetes
por: Pratley, Richard E
Publicado: (2014)

Empagliflozin/linagliptin: Euglycaemic diabetic ketoacidosis: case report
Publicado: (2021)

Linagliptin as add-on therapy to insulin for patients with type 2 diabetes
por: von Websky, Karoline, et al.
Publicado: (2013)

Endothelial effects of antihypertensive treatment: focus on irbesartan
por: Negro, Roberto
Publicado: (2008)

Comparative Efficacy of Irbesartan/ Hydrochlorothiazide and Valsartan/Hydrochlorothiazide Combination in Lowering Blood Pressure: A Retrospective Observational Study in Oman
por: Al Balushi, K.A., et al.
Publicado: (2013)

Linagliptin: from bench to bedside
por: Doupis, John
Publicado: (2014)

Endothelial function, blood pressure control, and risk modification: impact of irbesartan alone or in combination
por: Derosa, Giuseppe, et al.
Publicado: (2010)

Therapeutic effect of irbesartan combined with atorvastatin calcium in the treatment of rats with coronary heart disease
por: Li, Tao, et al.
Publicado: (2018)

Initial combination of linagliptin and metformin in patients with type 2 diabetes: efficacy and safety in a randomised, double-blind 1-year extension study
por: Haak, T, et al.
Publicado: (2013)

Population Pharmacokinetics and Pharmacodynamics of Linagliptin in Patients with Type 2 Diabetes Mellitus
por: Retlich, Silke, et al.
Publicado: (2015)

Effects of Linagliptin on Pancreatic α Cells of Type 1 Diabetic Mice
por: Zhang, Yanqing, et al.
Publicado: (2017)

Long-term use and tolerability of irbesartan for control of hypertension
por: Forni, Valentina, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_22ogi423d5h0t3pen9scqs1jj1